The role of M0, M2 macrophages in tumor immune microenvironment is consistent with the favorable genes of CHIT1, SIGLEC15, PLA2G2D and TMEM163 for the prognosis of lymphoma patients. This evidence concerns the gene TMEM163 and neoplasm.